News

News Room

2024.05.31

Significant Milestone! First Patient Enrolled in Phase I Clinical Trial of Neuboron's BNCT Drug-Device Product
News
First in China! Neuboron’s BNCT Drug-Device Product Phase I Registration Clinical Trial Launched at Xiamen Humanity Hospital

2024.04.24

476
News
Major Progress! Neuboron's Accelerator-Based BNCT Treatment System "NeuPEX Block-I" Passes Registration Inspection

2024.03.31

691
News
Good News | Neuboron Receives Another National Key Project Approval

2024.01.15

596
News
China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

2024.01.09

1007
News
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

2023.12.13

3384
News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15

4776
News
Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

2023.08.14

4533
News
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

2023.05.09

5461
News
China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

2023.01.31

5906
News
In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

2022.08.30

5632
News
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

2022.03.25

5472
News
Happy 2022 and everything goes well

2021.12.31

5721
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

2021.11.10

6750
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01

6867

Events

News Room

Significant Milestone! First Patient Enrolled in Phase I Clinical Trial of Neuboron's BNCT Drug-Device Product

First in China! Neuboron’s BNCT Drug-Device Product Phase I Registration Clinical Trial Launched at Xiamen Humanity Hospital

Major Progress! Neuboron's Accelerator-Based BNCT Treatment System "NeuPEX Block-I" Passes Registration Inspection

Good News | Neuboron Receives Another National Key Project Approval

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

Happy 2022 and everything goes well

Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference